Drugs / CNK-UT
CNK-UT
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06751134 | Dec 2024 → Jul 2026 overdue | neuroblastoma | Nanjing Children's Hospital | Recruiting | No outcome recorded |
| Phase 1 | NCT06750133 | Dec 2024 → Dec 2025 overdue | acute graft versus host disease | First Affiliated Hospital of Zhejiang University | Recruiting | No outcome recorded |
| Phase 1 | NCT06568328 | Sep 2024 → Jan 2026 overdue | graft versus host disease | Fujian Medical University | Recruiting | No outcome recorded |
| Phase 1 | NCT05976906 | May 2023 → May 2025 | cancer | Zhejiang University | Unknown | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CNK-UT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06568328 ↗ |
| Known as | Chimeric Natural Killer Receptor Universal T-cells | “Chimeric Natural Killer Receptor Universal T-cells (CNK-UT)” NCT06568328 ↗2“Chimeric Natural Killer Receptor Universal T-cells (CNK-UT)” NCT06751134 ↗ “Chimeric Natural Killer Receptor Universal T-cells (CNK-UT)” NCT06750133 ↗ |
| Known as | CNK-UT cells | “A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy, Pharmacodynamics and Immunogenicity of Universal CNK-UT Cells in Patients With Advanced Solid Tumors.” NCT05976906 ↗ |
| Known as | Universal Chimeric Natural Killer Receptor Modified T-cells | “Universal Chimeric Natural Killer Receptor Modified T-cells (CNK-UT)” NCT05976906 ↗ |
| Known as | Universal CNK-UT Cells | “A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy, Pharmacodynamics and Immunogenicity of Universal CNK-UT Cells in Patients With Advanced Solid Tumors.” NCT05976906 ↗ |
| Modality | Cell therapy | “Universal Dual-target NKG2D-NKp44 CAR-T Cells” NCT05976906 ↗ |
| Route | Intravenous | “Intravenous injection of CNK-UT cells directly.” NCT05976906 ↗ |